These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 7478621)
1. Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Russo D; Arturi F; Schlumberger M; Caillou B; Monier R; Filetti S; Suárez HG Oncogene; 1995 Nov; 11(9):1907-11. PubMed ID: 7478621 [TBL] [Abstract][Full Text] [Related]
2. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation. Du Villard JA; Wicker R; Crespo P; Russo D; Filetti S; Gutkind JS; Sarasin A; Suárez HG Oncogene; 2000 Oct; 19(42):4896-905. PubMed ID: 11039907 [TBL] [Abstract][Full Text] [Related]
3. gsp mutations in human thyroid tumours. Suarez HG; du Villard JA; Caillou B; Schlumberger M; Parmentier C; Monier R Oncogene; 1991 Apr; 6(4):677-9. PubMed ID: 1903197 [TBL] [Abstract][Full Text] [Related]
4. Thyrotropin receptor: a role for thyroid tumourigenesis? Russo D; Arturi F; Chiefari E; Filetti S Forum (Genova); 1999; 9(2):166-75. PubMed ID: 10385711 [TBL] [Abstract][Full Text] [Related]
5. The detection of somatic mutations of thyrotropin receptor gene in fine needle biopsy samples from thyroid nodules. Syrenicz A; Kurzawski G; Ciechanowicz A Endocr Regul; 1999 Sep; 33(3):95-101. PubMed ID: 10571960 [TBL] [Abstract][Full Text] [Related]
6. Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin. Motoi N; Sakamoto A; Yamochi T; Horiuchi H; Motoi T; Machinami R Pathol Res Pract; 2000; 196(1):1-7. PubMed ID: 10674266 [TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of the TSH receptor gene in differentiated human thyroid carcinomas. Cetani F; Tonacchera M; Pinchera A; Barsacchi R; Basolo F; Miccoli P; Pacini F J Endocrinol Invest; 1999 Apr; 22(4):273-8. PubMed ID: 10342361 [TBL] [Abstract][Full Text] [Related]
8. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. Russo D; Arturi F; Suarez HG; Schlumberger M; Du Villard JA; Crocetti U; Filetti S J Clin Endocrinol Metab; 1996 Apr; 81(4):1548-51. PubMed ID: 8636365 [TBL] [Abstract][Full Text] [Related]
9. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity. Neumann S; Krohn K; Chey S; Paschke R Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271 [TBL] [Abstract][Full Text] [Related]
10. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Parma J; Duprez L; Van Sande J; Cochaux P; Gervy C; Mockel J; Dumont J; Vassart G Nature; 1993 Oct; 365(6447):649-51. PubMed ID: 8413627 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of RAS point mutations in papillary thyroid carcinoma; a novel mutation at codon 31 of K-RAS. Cyniak-Magierska A; Brzeziańska E; Januszkiewicz-Caulier J; Jarzab B; Lewiński A Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):594-9. PubMed ID: 17943694 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident. Nikiforov YE; Nikiforova MN; Gnepp DR; Fagin JA Oncogene; 1996 Aug; 13(4):687-93. PubMed ID: 8761289 [TBL] [Abstract][Full Text] [Related]
13. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. Garcia-Rostan G; Zhao H; Camp RL; Pollan M; Herrero A; Pardo J; Wu R; Carcangiu ML; Costa J; Tallini G J Clin Oncol; 2003 Sep; 21(17):3226-35. PubMed ID: 12947056 [TBL] [Abstract][Full Text] [Related]
14. The natural protein kinase C alpha mutant is present in human thyroid neoplasms. Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730 [TBL] [Abstract][Full Text] [Related]
15. Somatic mutations in the VI transmembrane segment of the thyrotropin receptor constitutively activate cAMP signalling in thyroid hyperfunctioning adenomas. Porcellini A; Ciullo I; Pannain S; Fenzi G; Avvedimento E Oncogene; 1995 Sep; 11(6):1089-93. PubMed ID: 7566968 [TBL] [Abstract][Full Text] [Related]
16. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms. Matsuo K; Friedman E; Gejman PV; Fagin JA J Clin Endocrinol Metab; 1993 Jun; 76(6):1446-51. PubMed ID: 8501149 [TBL] [Abstract][Full Text] [Related]
17. Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes. Niepomniszcze H; Suárez H; Pitoia F; Pignatta A; Danilowicz K; Manavela M; Elsner B; Bruno OD Thyroid; 2006 May; 16(5):497-503. PubMed ID: 16756473 [TBL] [Abstract][Full Text] [Related]
18. [Specific amplification by PCR for N-ras mutation in thyroid follicular cartinoma]. Taniyama M; Kaihara M Nihon Rinsho; 1994 Apr; 52(4):1075-80. PubMed ID: 8196166 [TBL] [Abstract][Full Text] [Related]
19. G protein and thyrotropin receptor mutations in thyroid neoplasia. Esapa C; Foster S; Johnson S; Jameson JL; Kendall-Taylor P; Harris PE J Clin Endocrinol Metab; 1997 Feb; 82(2):493-6. PubMed ID: 9024242 [TBL] [Abstract][Full Text] [Related]